Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-5038Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mattli, Renato | - |
| dc.contributor.author | Eichler, Klaus | - |
| dc.contributor.author | Pletscher, Mark | - |
| dc.contributor.author | Wieser, Simon | - |
| dc.date.accessioned | 2019-03-07T13:54:13Z | - |
| dc.date.available | 2019-03-07T13:54:13Z | - |
| dc.date.issued | 2013 | - |
| dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/15874 | - |
| dc.description.abstract | Febrile neutropenia (FN) can be a serious complication of chemotherapy (CHT), increasing mortality risk and healthcare costs. Incidence and inpatient hospital costs of FN in Switzerland are currently not reported. The study aimed to: 1. Estimate the number of CHT induced FN-related hospitalizations. 2. Assess inpatient hospital costs per FN event in Switzerland. | de_CH |
| dc.language.iso | en | de_CH |
| dc.publisher | ZHAW Zürcher Hochschule für Angewandte Wissenschaften | de_CH |
| dc.rights | Licence according to publishing contract | de_CH |
| dc.subject.ddc | 362.1041: Gesundheitsökonomie | de_CH |
| dc.subject.ddc | 362.11: Krankenhäuser und verwandte Einrichtungen | de_CH |
| dc.title | Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland | de_CH |
| dc.type | Konferenz: Poster | de_CH |
| dcterms.type | Text | de_CH |
| zhaw.departement | School of Management and Law | de_CH |
| dc.identifier.doi | 10.21256/zhaw-5038 | - |
| zhaw.conference.details | ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013 | de_CH |
| zhaw.funding.eu | No | de_CH |
| zhaw.originated.zhaw | Yes | de_CH |
| zhaw.publication.status | publishedVersion | de_CH |
| zhaw.publication.review | Peer review (Abstract) | de_CH |
| Appears in collections: | Publikationen School of Management and Law | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2013_Mattli_Inpatient_hospital_costs_of_febrile_neutropenia_as_a_consequence_of_chemotherapy.pdf | 102.67 kB | Adobe PDF |  View/Open |
Show simple item record
Mattli, R., Eichler, K., Pletscher, M., & Wieser, S. (2013). Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland. ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. https://doi.org/10.21256/zhaw-5038
Mattli, R. et al. (2013) ‘Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland’, in ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Available at: https://doi.org/10.21256/zhaw-5038.
R. Mattli, K. Eichler, M. Pletscher, and S. Wieser, “Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland,” in ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013, 2013. doi: 10.21256/zhaw-5038.
MATTLI, Renato, Klaus EICHLER, Mark PLETSCHER und Simon WIESER, 2013. Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerland. In: ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. Conference poster. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. 2013
Mattli, Renato, Klaus Eichler, Mark Pletscher, and Simon Wieser. 2013. “Inpatient Hospital Costs of Febrile Neutropenia as a Consequence of Chemotherapy for Breast Cancer and Non-Hodgkin Lymphoma in Switzerland.” Conference poster. In ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. https://doi.org/10.21256/zhaw-5038.
Mattli, Renato, et al. “Inpatient Hospital Costs of Febrile Neutropenia as a Consequence of Chemotherapy for Breast Cancer and Non-Hodgkin Lymphoma in Switzerland.” ISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013, ZHAW Zürcher Hochschule für Angewandte Wissenschaften, 2013, https://doi.org/10.21256/zhaw-5038.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.